Showing 41 - 60 results of 94 for search '"drug safety"', query time: 0.07s Refine Results
  1. 41
  2. 42

    Improving ADR reporting in Jordan: a qualitative exploration of pharmacists’ perspectives by Amal K. Suleiman

    Published 2025-01-01
    “…Hence, they have a crucial role in ensuring drug safety by detecting and reporting adverse drug reactions (ADRs). …”
    Get full text
    Article
  3. 43

    Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database by Wenwen Zhang, Yizhen Yin, Dan Yang, Mengyuan Liu, Caixia Ye, Ruiling Yan, Ruiman Li

    Published 2025-01-01
    “…Food and Drug Administration’s Adverse Event Reporting System (FAERS) database to assess the drug safety profile of Zolgensma. A total of 1951 adverse event reports associated with onasemnogene abeparvovec (Zolgensma), containing 778 import important medical event (IME) signals, were identified from the FAERS database, and multiple disproportionate analysis algorithms were used to determine the significance of these adverse events. …”
    Get full text
    Article
  4. 44

    Clinical Efficacy and Safety Analysis of Levofloxacin for the Prevention of Infection after Traumatic Osteoarthrosis and Internal Fixation: Systematic Review and Meta-Analysis by Weiliang Wang, ChuanQi Zou, Jie Zhang

    Published 2022-01-01
    “…Newsletter and FDA Drug Safety Newsletter, also to retrieve the Websites of Chinese, Chinese, and drug regulatory authorities; To obtain data on adverse events in children with systemic administration of levofloxacin. …”
    Get full text
    Article
  5. 45

    Rapid Detection of Pesticide Residues in Chinese Herbal Medicines by Fourier Transform Infrared Spectroscopy Coupled with Partial Least Squares Regression by Tianming Yang, Rong Zhou, Du Jiang, Haiyan Fu, Rui Su, Yangxi Liu, Hanbo Su

    Published 2016-01-01
    “…In conclusion, FT-IR spectroscopy in combination with PLSR has been demonstrated for its application in rapid screening and quantitative analysis of multipesticide residues in Chinese herbal medicines without physical or chemical separation pretreatment step and any spectral processing, which also implies other potential applications such as food and drug safety, herbal plants quality, and environmental evaluation, due to its advantages of nontoxic and nondestructive analysis.…”
    Get full text
    Article
  6. 46

    HDN-DDI: a novel framework for predicting drug-drug interactions using hierarchical molecular graphs and enhanced dual-view representation learning by Jinchen Sun, Haoran Zheng

    Published 2025-01-01
    “…Conclusion With its accurate predictions and robust generalization across different settings, HDN-DDI shows promise for enhancing drug safety and efficacy. Future research will focus on refining decomposition rules as well as integrating external knowledge while preserving the model’s generalization capabilities.…”
    Get full text
    Article
  7. 47

    Acorus shannai (Acoraceae), a new species from Southern China by Zhuo Cheng, Xinyu Liu, Nianting Yu, Weizhe Chen, Haofeng Zhao, Feifei Li, Chunlin Long

    Published 2025-01-01
    “…The recognition of A. shannai is not only important for the species diversity and phylogenetic relationship of Acorus, but also can avoid the drug safety caused by using other Acorus species as A. shannai to eat and promote the conservation of A. shannai resources.…”
    Get full text
    Article
  8. 48

    Deanxit Combined with Cognitive Behavioral Therapy in Treating 31 Cases of Post-stroke Depression by Dujuan GE, Liyu WU, Sanfeng SUN, Lei SHANG, Qingjuan YANG, Xiaoru YANG, Qingxi ZHAO

    Published 2016-04-01
    “…The curative effect was assessed by Hamilton depression scale (HAMD), the neurologic function recovery was measured by national institutes of health stroke scale (NIHSS) and modified Barthel index (MBI), and the drug safety was evaluated by treatment emergent symptom scale (TESS).Results:After two courses, the total effective rate of the experimental group (93.5%) was higher than that of the control group (79.3%), and the difference was significant (<italic>P</italic>&lt;0.05); after a course of treatment, the HAMD score in the two groups was decreased significantly compared with that before the treatment (<italic>P</italic>&lt;0.01); the weekly score in the treatment group was lower than that of the control group, and the difference was significant at the first weekend and the second weekend (<italic>P</italic>&lt;0.05, <italic>P</italic>&lt;0.01). …”
    Get full text
    Article
  9. 49
  10. 50
  11. 51

    Beyond boundaries: Charting the frontier of healthcare with big data and ai advancements in pharmacovigilance by Arohi Agarwal, Gagan Singh, Samyak Jain, Piyush Mittal

    Published 2025-03-01
    “…It delves into the notable benefits and challenges encountered in advancing data analytics of the early 21st century.In many countries, Post-marketing surveillance of drug safety relinquishes on a systematic analysis of spontaneous using Generative artificial intelligence (AI) to overcome gaps in the present PV ecosystem is critical to maintaining an uninterrupted record of security and effectiveness within healthcare analytics, data mining techniques, predictive analytics, and the emergence of scientific fields like bioinformatics and health informatics are empowered by Big Data. …”
    Get full text
    Article
  12. 52
  13. 53

    Synergistic activity of Pitstop-2 and 1,6-hexanediol in aggressive human lung cancer cells by Sílvio Terra Stefanello, Caren Rigon Mizdal, Aline Franzen da Silva, Luca Matteo Todesca, Félix Alexandre Antunes Soares, Victor Shahin

    Published 2025-01-01
    “…Moreover, motility assays show that the compounds combination significantly impedes the motility of all cells. Drug safety and tolerability assessments were validated using the in vivo model organism Caenorhabditis elegans, where fairly high doses showed negligible impact on survival, development, or behavioral parameters. …”
    Get full text
    Article
  14. 54

    Association of expedited review programmes with postmarketing safety events of new drugs approved by the US food and drug administration between 2007 and 2017 by Bao Liu, Xingyue Zhu

    Published 2022-07-01
    “…Objective To explore the associations between the risks of postmarketing safety events of new drugs and the four expedited programmes of priority review, accelerated approval, fast track and breakthrough therapy established by the US Food and Drug Administration (FDA); and to investigate whether multiple uses of expedited programmes, and the combinations of expedited programmes with orphan designation, were relevant to different safety profiles.Design Cohort study.Setting USA.Participants All new drugs approved by the FDA between 1 January 2007 and 31 December 2017, followed up until 10 April 2021.Outcome measures Safety events included safety-related withdrawal, new boxed warning, drug safety communication, postapproval risk evaluation mitigation strategy and safety-related labelling changes. …”
    Get full text
    Article
  15. 55

    A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital by Nancy Khajuria, Nikhil Menia, Seema Gupta

    Published 2024-12-01
    “…It is of utmost importance to closely monitor and manage adverse drug reactions (ADRs) in paediatric oncology, emphasising the importance of implementing improved drug safety measures.…”
    Get full text
    Article
  16. 56

    Knowledge, Attitude, Practice, and Barriers of Adverse Drug Reaction Reporting Among Healthcare Professionals in Timor‐Leste: A Cross‐Sectional Survey by Juanina daCosta, Wichit Nosoongnoen, Watcharee Rungapiromnan, Pramote Tragulpiankit

    Published 2025-01-01
    “…Positive attitudes were observed, with 53.4% agreeing that ADR reporting is crucial for drug safety, although only 22.0% reported observed ADRs. …”
    Get full text
    Article
  17. 57

    Postpartum changes in maternal physiology and milk composition: a comprehensive database for developing lactation physiologically-based pharmacokinetic models by Neel Deferm, Neel Deferm, Jean Dinh, Jean Dinh, Amita Pansari, Masoud Jamei, Khaled Abduljalil

    Published 2025-02-01
    “…IntroductionPharmacotherapy during lactation often lacks reliable drug safety data, resulting in delayed treatment or early cessation of breastfeeding. …”
    Get full text
    Article
  18. 58
  19. 59

    hERGAT: predicting hERG blockers using graph attention mechanism through atom- and molecule-level interaction analyses by Dohyeon Lee, Sunyong Yoo

    Published 2025-01-01
    “…Our model achieved an area under the receiver operating characteristic of 0.907 and an area under the precision-recall of 0.904, demonstrating its effectiveness in modeling hERG activity and offering a reliable framework for optimizing drug safety in early development stages. Scientific contribution: hERGAT is a deep learning model for predicting hERG blockers by combining GAT and GRU, enabling it to capture complex interactions at atomic and molecular levels. …”
    Get full text
    Article
  20. 60

    Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana by Abraham Rexford Oduro, Samuel Chatio, Paula Beeri, Thomas Anyorigiya, Rita Baiden, Philip Adongo, Patricia Akweongo

    Published 2019-01-01
    “…Follow-up visits were made on days 3 and 28 after diagnosis to collect data on adherence, drug safety and therapeutic effectiveness. During follow-up visits, in-depth interviews were conducted and the blister packs directly observed for the number of tablets remaining. …”
    Get full text
    Article